Apitope Plans 2013 Financing to Advance Autoimmune Drugs

LONDON – Apitope Ltd. is busy drawing up the business plan for a double-digit financing round to take its next two projects through Phase I development after triggering a key clinical milestone in its lead multiple sclerosis program.